| Title |
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, December 2012
|
| DOI | 10.1007/s10549-012-2378-9 |
| Pubmed ID | |
| Authors |
Cynthia X. Ma, Matthew J. C. Ellis, Gina R. Petroni, Zhanfang Guo, Shi-rong Cai, Christine E. Ryan, A. Craig Lockhart, Michael J. Naughton, Timothy J. Pluard, Christiana M. Brenin, Joel Picus, Allison N. Creekmore, Tibu Mwandoro, Erin R. Yarde, Jerry Reed, Mark Ebbert, Philip S. Bernard, Mark Watson, Laurence A. Doyle, Janet Dancey, Helen Piwnica-Worms, Paula M. Fracasso |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 2 | 2% |
| France | 1 | 1% |
| Unknown | 90 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 18% |
| Student > Ph. D. Student | 13 | 14% |
| Student > Bachelor | 13 | 14% |
| Other | 12 | 13% |
| Student > Doctoral Student | 7 | 8% |
| Other | 16 | 17% |
| Unknown | 15 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 26 | 28% |
| Medicine and Dentistry | 21 | 23% |
| Biochemistry, Genetics and Molecular Biology | 16 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Chemistry | 3 | 3% |
| Other | 7 | 8% |
| Unknown | 16 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2023.
All research outputs
#3,232,956
of 24,387,992 outputs
Outputs from Breast Cancer Research and Treatment
#487
of 4,851 outputs
Outputs of similar age
#31,819
of 287,750 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#12
of 63 outputs
Altmetric has tracked 24,387,992 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,851 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,750 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.